Keywords: healthy, pharma, sales, akzo, nobel, dutch, chemical
Healthy pharma sales for Akzo Nobel
Article | 23 April 1999
Dutch chemical and pharmaceutical group Akzo Nobel reportedfirst-quarter 1999 net income of 173 million euros ($162.2 million), down 7%, on sales of 3.4 billion euros, ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscribe now
for unlimited access to all articles
Subscriptions are £60 per month, pay as you go.
Find out more details.
Already a subscriber? Click here to log in
- Is failure to adopt business process management putting the pharma industry at risk?
- AstraZeneca's naloxegol meets endpoints; EMA validates Gilead's sofosbuvir MAA
- Ignyta acquires Actagene Oncology and entry into cancer personalized medicine
- Sanofi and Regeneron's dupilumab shows 87% reduction in risk of asthma exacerbations
- Boehringer Ingelheim gets FDA warning letter on cGMP failures
